Danish guidelines for management of non-APC-associated hereditary polyposis syndromes

Anne Marie Jelsig; John Gásdal Karstensen; Niels Jespersen; Zohreh Ketabi; Charlotte Lautrup; Karina Rønlund; Lone Sunde; Karin Wadt; Ole Thorlacius-Ussing; Niels Qvist

doi:10.1186/s13053-021-00197-8

Danish guidelines for management of non-APC-associated hereditary polyposis syndromes

Anne Marie Jelsig^*, John Gásdal Karstensen, Niels Jespersen, Zohreh Ketabi, Charlotte Lautrup, Karina Rønlund, Lone Sunde, Karin Wadt, Ole Thorlacius-Ussing, Niels Qvist

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avis › Review › Forskning › peer review

10 Citationer (Scopus)

Abstract

Hereditary Polyposis Syndromes are a group of rare, inherited syndromes characterized by the presence of histopathologically specific or numerous intestinal polyps and an increased risk of cancer. Some polyposis syndromes have been known for decades, but the development in genetic technologies has allowed the identification of new syndromes.. The diagnosis entails surveillance from an early age, but universal guideline on how to manage and surveille these new syndromes are lacking. This paper represents a condensed version of the recent guideline (2020) from a working group appointed by the Danish Society of Medical Genetics and the Danish Society of Surgery on recommendations for the surveillance of patients with hereditary polyposis syndromes, including rare polyposis syndromes.

Originalsprog	Engelsk
Artikelnummer	41
Tidsskrift	Hereditary Cancer in Clinical Practice
Vol/bind	19
Nummer	1
ISSN	1731-2302
DOI	https://doi.org/10.1186/s13053-021-00197-8
Status	Udgivet - okt. 2021
Udgivet eksternt	Ja

Adgang til dokumentet

10.1186/s13053-021-00197-8Licens: CC BY

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{52987395dfb24a358c20f4592216b15c,

title = "Danish guidelines for management of non-APC-associated hereditary polyposis syndromes",

abstract = "Hereditary Polyposis Syndromes are a group of rare, inherited syndromes characterized by the presence of histopathologically specific or numerous intestinal polyps and an increased risk of cancer. Some polyposis syndromes have been known for decades, but the development in genetic technologies has allowed the identification of new syndromes.. The diagnosis entails surveillance from an early age, but universal guideline on how to manage and surveille these new syndromes are lacking. This paper represents a condensed version of the recent guideline (2020) from a working group appointed by the Danish Society of Medical Genetics and the Danish Society of Surgery on recommendations for the surveillance of patients with hereditary polyposis syndromes, including rare polyposis syndromes.",

keywords = "Cancer, Genetics, Guideline, Hereditary, Management, Polyposis, Surveillance",

author = "Jelsig, {Anne Marie} and Karstensen, {John G{\'a}sdal} and Niels Jespersen and Zohreh Ketabi and Charlotte Lautrup and Karina R{\o}nlund and Lone Sunde and Karin Wadt and Ole Thorlacius-Ussing and Niels Qvist",

note = "{\textcopyright} 2021. The Author(s).",

year = "2021",

month = oct,

doi = "10.1186/s13053-021-00197-8",

language = "English",

volume = "19",

journal = "Hereditary Cancer in Clinical Practice",

issn = "1731-2302",

publisher = "BMC",

number = "1",

}

TY - JOUR

T1 - Danish guidelines for management of non-APC-associated hereditary polyposis syndromes

AU - Jelsig, Anne Marie

AU - Karstensen, John Gásdal

AU - Jespersen, Niels

AU - Ketabi, Zohreh

AU - Lautrup, Charlotte

AU - Rønlund, Karina

AU - Sunde, Lone

AU - Wadt, Karin

AU - Thorlacius-Ussing, Ole

AU - Qvist, Niels

PY - 2021/10

Y1 - 2021/10

N2 - Hereditary Polyposis Syndromes are a group of rare, inherited syndromes characterized by the presence of histopathologically specific or numerous intestinal polyps and an increased risk of cancer. Some polyposis syndromes have been known for decades, but the development in genetic technologies has allowed the identification of new syndromes.. The diagnosis entails surveillance from an early age, but universal guideline on how to manage and surveille these new syndromes are lacking. This paper represents a condensed version of the recent guideline (2020) from a working group appointed by the Danish Society of Medical Genetics and the Danish Society of Surgery on recommendations for the surveillance of patients with hereditary polyposis syndromes, including rare polyposis syndromes.

AB - Hereditary Polyposis Syndromes are a group of rare, inherited syndromes characterized by the presence of histopathologically specific or numerous intestinal polyps and an increased risk of cancer. Some polyposis syndromes have been known for decades, but the development in genetic technologies has allowed the identification of new syndromes.. The diagnosis entails surveillance from an early age, but universal guideline on how to manage and surveille these new syndromes are lacking. This paper represents a condensed version of the recent guideline (2020) from a working group appointed by the Danish Society of Medical Genetics and the Danish Society of Surgery on recommendations for the surveillance of patients with hereditary polyposis syndromes, including rare polyposis syndromes.

KW - Cancer

KW - Genetics

KW - Guideline

KW - Hereditary

KW - Management

KW - Polyposis

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=85116618898&partnerID=8YFLogxK

U2 - 10.1186/s13053-021-00197-8

DO - 10.1186/s13053-021-00197-8

M3 - Review

C2 - 34620187

SN - 1731-2302

VL - 19

JO - Hereditary Cancer in Clinical Practice

JF - Hereditary Cancer in Clinical Practice

IS - 1

M1 - 41

ER -

Danish guidelines for management of non-APC-associated hereditary polyposis syndromes

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater